评价Nitrosylcobalamin与内在因子的结合亲和力,作为Cobalamin结合蛋白相互作用的预测模型:与Hydroxocobalamin进行比较研究
Annette M Sysel1, Joseph A Bauer2
1Bauer Research Foundation, Inc., Akron, OH 44312, USA.
Frontiers in bioscience (Elite edition)
|March 28, 2025
概括
尼甲胺 (NO-Cbl) 和甲胺 (OH-Cbl) 强烈与内在因子 (IF) 结合,OH-Cbl的亲和力略高. 植物衍生IF是评估可巴拉胺模拟结合和治疗潜力的合适模型.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内在因素 (IF) 对于维生素B12的吸收至关重要.
- 科巴胺类同类物,如尼赛尔科巴胺 (NO-Cbl) 和氧科巴胺 (OH-Cbl),正在研究治疗应用.
- 重组植物衍生IF作为研究巴胺相互作用的模型系统.
研究的目的:
- 评估NO-Cbl与植物衍生的内在因子 (IF) 的结合亲和力.
- 为了将NO-Cbl与可胺 (OH-Cbl) 的结合与IF进行比较.
- 评估植物衍生IF的实用性,作为可拉胺类型相互作用的模型.
主要方法:
- 使用表面等离子体共振 (SPR) 来测量结合动力学.
- 对于与IF结合的NO-Cbl和OH-Cbl,确定了动力参数,包括平衡解离常数 (KD).
- 研究了不同度的可巴胺类型的相互作用.
主要成果:
- 无论是NO-Cbl还是OH-Cbl,都表现出对IF的高结合亲缘关系,KD值处于皮科莫尔范围.
- 与NO-Cbl (KD = 8.58 × 10−11 M) 相比,OH-Cbl的结合亲和力略高 (KD = 4.79 × 10−11 M).
- 在NO-Cbl和OH-Cbl之间观察到结合亲和力和稳定性的差异,特别是在更高度下.
结论:
- 植物IF与原生人类IF相比,具有细微的结合差异,可能是由于位点和或识别变化.
- NO-Cbl显示出作为一种向治疗剂的潜力,利用自然可巴胺吸收通路.
- 重组植物衍生IF是预测可巴拉胺类同类物生物活性的合适模型.
相关概念视频
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Protein-Drug Binding: Determination Methods
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...


